Developing gene therapies for cancer and small molecules for inflammation.
Industry: Health Care
First Day Return: -2.5%
IPO Data | |
---|---|
IPO Date | 09/30/2014 |
Offer Price | IPO Intelligence Only |
Price Range | IPO Intelligence Only |
Offer Shares (mm) | IPO Intelligence Only |
Deal Size ($mm) | $40 |
Lock-Up Date | IPO Intelligence Only |
Street Research | IPO Intelligence Only |
Underwriters |
---|
IPO Intelligence Only |
Company Data | |
---|---|
Headquarters | Or Yehuda, Israel |
Founded | 2000 |
Employees at IPO | 32 |
Website www.vblrx.com |